Part I: Recognizing Suicidal Ideation and Behavior in Individuals with First Episode Psychosis
The Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Mental Health Services (CMHS) is sponsoring a two-part series on Recognizing and Addressing Suicidal Ideation and Behavior in individuals with a First Episode of Psychosis (FEP).
Background: Individuals with schizophrenia and other psychoses are at heightened risk of suicide. According to the Centers for Disease Control, "Persons with schizophrenia pose a high risk for suicide. Approximately one-third will attempt suicide and, eventually, about 1 out of 10 will take their own lives." NIMH, in their White Paper on Coordinated Specialty Care (CSC) services for individuals experiencing a first episode of psychosis, recommends that: “… CSC staff members must understand common problems that cut across all service categories, such as difficulties in engaging the client and their family members, clients’ vulnerability for developing substance use problems, and heightened risk of suicide during the early years of treatment.” To assist States and block grant funded FEP providers in recognizing and addressing suicidal risks in their clients, SAMHSA/CMHS is sponsoring two virtual sessions that address the issues of identifying and addressing suicidal ideation and behavior.
Part 1: Recognizing Suicidal Ideation and Behavior in Individuals with First Episode Psychosis
Description: Part 1 of this two-part series focused on the strategies and tools available to providers and public health authorities to identify and monitor suicidal ideation and behavior. Specific focus was paid to addressing suicidality among individuals with schizophrenia, and how it is unique for individuals with a first episode of psychosis. The presenters have expertise in developing instruments to assess and identify suicidal ideation (specifically the Columbia Suicide Severity Rating Scale), and have experience implementing these tools in clinical settings for individuals with first episodes of psychosis (OnTrack and EDAPT).
Date & Time: June 28th, 2016, from 2:00-3:30 PM Eastern Time
•Barbara Stanley, Ph.D., Professor of Medical Psychology, Columbia University Medical Center
•Jill Harkavy-Friedman, Ph.D., Vice President of Research, American Foundation for Suicide Prevention, Suicide Risk Prevention in FEP
•Yael Holoshitz, M.D., Psychiatrist, Columbia University/New York State Psychiatric Institute
•Tara Niendam, Ph.D., Psychologist, Director of Operations, EDAPT and SacEDAPT Programs at UC Davis